How to Order Bactrim DS for UTI
For uncomplicated cystitis in adults, prescribe Bactrim DS (trimethoprim-sulfamethoxazole 160/800 mg) one tablet twice daily for 3 days, but ONLY if local resistance rates are below 20% or the organism is known to be susceptible. 1
Critical Decision Point: Check Local Resistance Rates First
Before prescribing Bactrim DS, you must verify that local E. coli resistance to trimethoprim-sulfamethoxazole is below 20%. This threshold is based on expert consensus that above this level, clinical and microbiological failure rates become unacceptably high 1. Studies demonstrate that when organisms are resistant to TMP-SMX, clinical cure drops dramatically from 84% to only 41% 1.
If local resistance exceeds 20%, choose nitrofurantoin instead (100 mg twice daily for 5 days), which remains first-line with minimal resistance 1, 2.
Specific Dosing Regimens by Clinical Scenario
Uncomplicated Cystitis (Lower UTI)
- Dose: 1 Bactrim DS tablet (160/800 mg) twice daily
- Duration: 3 days 1, 3
- Evidence: Multiple RCTs show 90-100% early clinical cure rates and 79-85% late cure rates with 3-day regimens 1
Uncomplicated Pyelonephritis (Upper UTI)
- Dose: 1 Bactrim DS tablet (160/800 mg) twice daily
- Duration: 14 days 1
- Critical caveat: Use ONLY if organism is known susceptible on culture
- Recommendation: Give one-time IV dose of ceftriaxone 1g or aminoglycoside before starting oral therapy if susceptibility unknown 1
UTI in Men
- Dose: 1 Bactrim DS tablet (160/800 mg) twice daily
- Duration: 7 days 2
- Note: Men require longer treatment than women due to potential prostatic involvement
FDA-Labeled Dosing (Per Package Insert)
The FDA label recommends 10-14 days for UTI treatment 4, but this is outdated. Current evidence-based guidelines support 3-day therapy for uncomplicated cystitis 1, 3, which achieves equivalent efficacy with fewer adverse effects (31% vs 38% with 7-day regimens) 1.
When NOT to Use Bactrim DS
Absolute contraindications for empirical use:
- Local TMP-SMX resistance >20% 1
- Recent TMP-SMX use (within 3 months)
- Pregnancy (especially first and third trimesters) 2
- Age <2 months 4
- Patients on renin-angiotensin system blockers + spironolactone (18 additional hyperkalaemia cases per 1000 treated) 5
Relative contraindications:
- CrCl 15-30 mL/min: reduce to half dose 4
- CrCl <15 mL/min: avoid use 4
- Elderly patients on ACE inhibitors/ARBs: 2.27-fold increased risk of hyperkalaemia 5
Common Pitfalls to Avoid
Don't prescribe 10-14 days for simple cystitis: This outdated practice increases adverse effects (38% vs 31%) without improving cure rates 1
Don't use empirically in high-resistance areas: The 2024 European guidelines now list TMP-SMX only as an "alternative" agent, not first-line, due to rising resistance 2
Don't ignore renal function: Acute kidney injury risk is 1.72-fold higher with trimethoprim vs amoxicillin 5
Don't use for pyelonephritis without culture: Unlike cystitis, pyelonephritis requires culture confirmation of susceptibility before TMP-SMX use 1
Monitoring Requirements
- No routine post-treatment cultures needed if symptoms resolve 2
- Obtain culture if symptoms persist beyond treatment or recur within 2 weeks 2
- Monitor potassium in elderly patients, especially those on ACE inhibitors/ARBs (2-fold increased hyperkalaemia risk) 5
Alternative First-Line Options (When TMP-SMX Inappropriate)
The evidence strongly supports these alternatives when Bactrim cannot be used:
- Nitrofurantoin: 100 mg twice daily × 5 days (90% cure rate, minimal resistance) 1, 2
- Fosfomycin: 3g single dose (slightly inferior efficacy but excellent for resistance patterns) 1, 2
- Pivmecillinam: 400 mg three times daily × 3-5 days (where available in Europe) 1, 2
Reserve fluoroquinolones for complicated infections or pyelonephritis due to collateral damage concerns and rising resistance 1.